Screener
Ardent Health Partners ARDT Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 97.4%-0.1pp | 97.5%-0.1pp | 97.5%0.0pp | 97.6%+0.1pp | 97.6%+0.1pp | |
| Net margin | 1.2%-2.9pp | 2.1%-1.6pp | 2.1%-1.4pp | 3.2%+1.6pp | 4.1%+2.5pp | |
| Returns | ||||||
| Return on equity | 6%-19.6pp | 10.7%-9.0pp | 11.2%-12.1pp | 18.3%+9.1pp | 25.6%+15.5pp | |
| Return on invested capital | 11.5%-11.3pp | 14.6%— | 9.4%-6.7pp | 20.5%— | 22.8%— | |
| Efficiency | ||||||
| Asset turnover | 1.2×0.0× | 1.3×— | 1.2×0.0× | 1.3×— | 1.3×— | |
| Liquidity | ||||||
| Current ratio | 2.1×0.0× | 2.1×0.0× | 2×0.0× | 2.1×+0.2× | 2.1×+0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×-0.1× | 0.9×-0.1× | 1.8×-0.2× | 0.9×-0.2× | 0.9×-0.6× | |
| Net debt / EBITDA | 1×0.0× | 1.1×0.0× | 3.3×+0.3× | 1×-0.4× | 1×-0.9× | |
| Per Share | ||||||
| Book value per share | $9.44+6.5% | $9.43+12.9% | $9.11+6.8% | $8.77+19.9% | $8.87+51.1% | |
| Valuation | ||||||
| Market capitalization | $1.46B-23.4% | $1.22B-37.7% | $1.26B-48.1% | $1.9B— | $1.89B— | |
| Price / earnings | 18.6×+9.4× | 9.1×+0.4× | 9.3×-2.3× | 9.2×— | 7.4×— | |
| Price / sales | 0.2×-0.1× | 0.2×-0.1× | 0.2×-0.2× | 0.3×— | 0.3×— | |
| Price / book | 1.1×-0.5× | 0.9×-0.8× | 1×-1.2× | 1.5×— | 1.5×— | |
| EV / EBITDA | 4.4×+0.2× | 3.6×-0.9× | 5.9×-1.4× | 4.3×— | 4×— |
FAQ
- Where do Ardent Health Partners's ratios come from?
- Every ratio is computed from Ardent Health Partners's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
